Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (201-210 of 237) with videos related to

Pageof 24
Sort By:
Pediatric Blood & Cancer|November 3, 2016
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosisRobert J Arceci, Carl E Allen, Ira J Dunkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Plos One|June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsOren J Becher, Nathan E Millard, Shakeel Modak, et al.
Neuro-Oncology|February 4, 2020
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium studyPatricia A Baxter, Jack M Su, Arzu Onar-Thomas, et al.
Neuro-Oncology|February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Cancer Medicine|July 8, 2020
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experiencePrachi Kothari, Francesco Marass, Julie L Yang, et al.
JAMA Ophthalmology|May 8, 2025
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA TestChuan Gao, Juber Patel, Melissa Robbins, et al.
Pediatric Blood & Cancer|May 26, 2017
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium studyMargaret E Macy, Mark W Kieran, Susan N Chi, et al.
Neuro-Oncology|August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)Michelle Monje, Tabitha Cooney, John Glod, et al.
Pediatric Blood & Cancer|January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)David Van Mater, Sridharan Gururangan, Oren Becher, et al.
Pageof 24

Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
Pediatric Blood & Cancer|November 3, 2016
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosisRobert J Arceci, Carl E Allen, Ira J Dunkel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Plos One|June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumorsOren J Becher, Nathan E Millard, Shakeel Modak, et al.
Neuro-Oncology|February 4, 2020
A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium studyPatricia A Baxter, Jack M Su, Arzu Onar-Thomas, et al.
Neuro-Oncology|February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Cancer Medicine|July 8, 2020
Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experiencePrachi Kothari, Francesco Marass, Julie L Yang, et al.
JAMA Ophthalmology|May 8, 2025
Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA TestChuan Gao, Juber Patel, Melissa Robbins, et al.
Pediatric Blood & Cancer|May 26, 2017
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium studyMargaret E Macy, Mark W Kieran, Susan N Chi, et al.
Neuro-Oncology|August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)Michelle Monje, Tabitha Cooney, John Glod, et al.
Pediatric Blood & Cancer|January 6, 2021
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042)David Van Mater, Sridharan Gururangan, Oren Becher, et al.
Pageof 24